iScan 80 OCT to launch in UK

Article

According to Haag-Streit UK, the iScan80 is a high-speed OCT system ideal for practices seeking an affordable and versatile OCT system.

Haag-Streit UK’s iScan80 offers a fully integrated system which includes a full suite of retina, optic nerve and anterior segment scans. (Image courtesy of Haag-Streit UK)

Haag-Streit UK’s iScan80 offers a fully integrated system which includes a full suite of retina, optic nerve and anterior segment scans. (Image courtesy of Haag-Streit UK)

Haag-Streit UK (HS-UK) is launching its Optovue iScan80 in the UK.

According to the company, a manufacturer and distributor of orthoptic, optometry and ophthalmic equipment, the iScan80 is a high-speed OCT system ideal for practices seeking an affordable and versatile OCT system.

The iScan80 now delivers high-speed 80kHz OCT at 80,000 A-scans per second, 3 times faster than the original iScan system. It offers a more simplified scan acquisition, and a wider field of view.

Compact and portable, the iScan80’s streamlined design integrates the operator interface, display, patient interface and scan head into one console, making it ideal for small spaces. The tabletop design offers the flexibility to place it in any room, or transfer from one practice to another.

The company noted the iScan80 offers a range of fantastic features, including an OCT iWellness scan, retina mapping, RNFL and Ganglion Cell Complex trend analysis, high-density 3D retinal imaging and in-depth 3D optic nerve head analysis. It also boasts a comprehensive range of anterior scans, including; pachymetry, epithelial mapping, angle scans and vault mapping.

Related Videos
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Dr Mary Elizabeth Hartnett speaks with David Hutton of Ophthalmology Times
Esen K. Akpek, MD, Professor at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, converses via zoom with David Hutton of Ophthalmology Times
© 2023 MJH Life Sciences

All rights reserved.